On Nov. 12, 2021, GlaxoSmithKline and Vir Biotechnology announced headline data from the randomised, multi-centre, open-label COMET-TAIL Phase…
On Sept. 21, 2021, the Medicines Patent Pool (MPP) announced that it had signed a licence agreement with…
On Nov. 12, 2021, Lincoln Children’s Zoo announced on Facebook that their three snow leopards: Ranney, Everest and…
On Nov. 11, 2021, Zipline, Pfizer and BioNTech announced that Zipline had successfully completed the first long-range drone…
On Nov. 11, 2021, Roche announced that the European Medicines Agencyï¾’s (EMA) Committee for Medicinal Products for Human…
On Nov. 11, 2021, Innovation Pharma reported topline results from the Companyï¾’s Phase 2 clinical trial of Brilacidin…
On Nov. 11, 2021, the University of Oxford began recruiting for a Phase I trial to test an…
On Nov. 10, 2021, a study by researchers at Georgia State University showed that the politicization of science…
On Nov. 10, 2021, Meridian Bioscience announced that their Revogeneï¾® SARS-CoV-2 assay was granted Emergency Use Authorization by…
On Nov. 10, 2021, the World Health Organization (WHO) announced that while reported measles cases had fallen compared…
On Nov. 10, 2021, the Biden-Harris Administration announced that it was increasing access to COVID-19 testing for Americans…
On Nov. 9, 2021, Swedish announced a $20 million personal bequest from the late philanthropist Paul G. Allen,…
On Nov. 9, 2021, Moderna announced that it has submitted for a variation to the conditional marketing authorization…
On Nov. 9, 2021, Novan announced promising preclinical safety results with berdazimer sodium in a 14-day GLP repeat…
On Nov. 9, 2021, Howard Hughes Medical Institute announced the program, named Codetta, can read the genome sequence…
On Nov. 8, 2021, Amyris announced announced it had entered into a 50:50 joint venture arrangement with ImmunityBio…
On Nov. 8, 2021, The U.S. Food and Drug Administration (FDA) reissued the emergency use authorization (EUA) for…
On Nov. 5, 2021, the USDAï¾’s (USDA) National Veterinary Services Laboratories announced confirmation of SARS-CoV-2 in two spotted…
On Nov. 5, 2021, scientists at the National Institutes of Health announced they had found that a process…
On Nov. 5, 2021, scientists at Oxford University announced they had identified the gene responsible for doubling the…
On Nov. 5, 2021, the U.S. Food and Drug Administration The FDA issued an emergency use authorization (EUA)…
On Nov. 5, 2021, Resverlogix announced that it had entered into a cooperation agreement with the Supreme Council…
On Nov. 3, 2021, Novavax announced the company had filed for provisional approval of the vaccine to the…
On Nov. 3, 2021, Innovation Pharma announced that the Company had received confirmation that hard lock of the…
On Nov. 3, 2021, Inovio Pharma announced that it had received authorization from India’s Central Drugs Standard Control…
On Nov. 3, 2021, the World Health Organization (WHO) issued an emergency use listing (EUL) for COVAXINï¾® (developed…
On Nov. 5, 2021, NRx Pharmaceuticals reported a safety update on ZYESAMIï¾® (aviptadil), which was being tested in…
On Nov. 2, 2021, OraSure Technologies announced that the EUA for its InteliSwabï¾™ COVID-19 rapid tests had been…
On Nov. 2, 2021, the National Institutes of Health announced support for a four-year follow-up study on the…
On Nov. 1, 2021, for the first time in the U.S., the transmission of COVID-19 from pet parent…